{
    "applicationNumber": "BR 11 2022 022995-0",
    "filingDate": "13/05/2021",
    "grantDate": null,
    "title": "DERIVADOS DE ESPIRO-SULFONAMIDA COMO INIBIDORES DA PROTE\u00cdNA DE LEUCEMIA-1 DE C\u00c9LULAS MIELOIDES (MCL-1)",
    "nationalPhaseDate": [
        "11/11/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2021/032263",
        "pctDate": "13/05/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/024,110",
            "priorityDate": "13/05/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2707"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2715"
        },
        {
            "code": "11.1",
            "description": "Arquivamento - Art. 33 da LPI",
            "bulletinNumber ": "2785"
        },
        {
            "code": "11.1.1",
            "description": "Arquivamento definitivo - Art. 33 da LPI",
            "bulletinNumber ": "2796"
        }
    ],
    "inventors": [
        "JINCONG ZHUO",
        "GANFENG CAO",
        "ANDREW PAUL COMBS",
        "QUN LI",
        "HUAPING ZHANG"
    ],
    "holders": [
        260404
    ],
    "ipcCodes": [
        "A61P 35/00",
        "C07D 515/04"
    ]
}